Saturday, December 21, 2024 | 12:03 PM ISTEN Hindi

Home / Content / B2B Connect / Pharma / JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US

JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US

It will expand biopharmaceutical manufacturing capacity at both its Durham and Boulder facilities

Premium

KBI Biopharma facility

BS B2B Bureau Durham, North Carolina (USA)

Last Updated : May 30 2017 | 6:03 PM IST

KBI Biopharma (KBI), a subsidiary of JSR Corporation (JSR), is expanding its biopharmaceutical manufacturing capacity and capabilities at both its Durham, North Carolina and Boulder, Colorado facilities. KBI will invest approximately $ 30 million in the two site expansion projects, which will greatly enhance the offerings at each site and are scheduled for completion later this year.

KBI is building commercial mammalian cell culture manufacturing capability within its Durham facility, which also houses cGMP cell culture manufacturing lines for clinical production. KBI’s strong development capabilities and track record of success in clinical bulk drug substance manufacturing are the foundation for its

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in